To support Montreal businesses during this exceptional situation, the Department of Economic Development of the City of Montreal has provided Montreal businesses and organizations with a dedicated telephone line, as well as a web form in order to facilitate the processing of requests for information, to meet the needs of businesses and to better understand their concerns in the particular context of COVID-19. This data set brings together some of the responses of businesses that contacted the City of Montreal, making it possible to draw up a certain portrait of the reality experienced by Montreal businesses. For more details on the measures put forward by the City of Montreal and the assistance programs available, visit the dedicated section on the City's website.

To support Montreal businesses during this exceptional situation, the Department of Economic Development of the City of Montreal has provided Montreal businesses and organizations with a dedicated telephone line, as well as a web form in order to facilitate the processing of information requests, meet the needs of businesses and better understand their concerns in the particular context of Covid-19. This data set brings together some of the responses of businesses that contacted the City of Montreal, making it possible to draw up a certain portrait of the reality experienced by Montreal businesses. For more details on the measures put forward by the City of Montreal and the assistance programs available, visit the dedicated section on the City's website.

In the context of the fight against COVID-19, the agglomeration of Montreal quickly redesigned public space to promote active and safe travel. The objective: to allow people to move around actively while respecting the physical distance instructions prescribed by the Public Health Department. This data set locates the ESTABLISHED health corridors as well as the PLANNED active and safe routes as reported by the boroughs and linked cities of the Agglomeration. The active and safe routes are presented as announced during the announcement on May 15, 2020. *Note: * This data is an image of corridors established and planned as of May 21, 2020, some changes made on the ground are not reflected in this set. For any additional information on the COVID-19 crisis, please consult the dedicated section on the City of Montreal's website.**This third party metadata element was translated using an automated translation tool (Amazon Translate).**

This is a phase 3, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of colchicine in adult patients diagnosed with COVID-19 infection and have at least one high-risk criterion. Approximately 6000 subjects meeting all inclusion and no exclusion criteria will be randomized to receive either colchicine or placebo tablets for 30 days.

This dataset was produced through the joint collection of Statistics Canada's Canadian Wastewater Survey (CWS) with the Public Health Agency of Canada. The CWS measures levels of SARS-CoV-2 in the wastewater of five Canadian municipalities: Vancouver, Edmonton, Toronto, Montreal, and Halifax. The dataset includes measurements by RT-qPCR of the concentration of SARS-CoV-2 and Pepper Mild Mottle Virus (PMMV) in wastewater from 2021/04/01 to 2021/12/15 reported in the Public Health Environmental Surveillance Open Data Model v1.1.

Pour soutenir les entreprises montréalaises durant cette situation exceptionnelle, le Service du développement économique de la Ville de Montréal a mis à la disposition des entreprises et des organisations montréalaises une ligne téléphonique dédiée, ainsi qu'un formulaire web afin de faciliter le cheminement des demandes d'information, de répondre aux besoins des entreprises et de mieux comprendre leurs préoccupations dans le contexte particulier de la COVID-19. Cet ensemble de données rassemble certains des éléments de réponse des entreprises qui ont communiqué avec la Ville de Montréal, permettant de dresser un certain portrait de la réalité vécue par les entreprises montréalaises.

Pour plus de détails sur les mesures mises de l'avant par la Ville de Montréal et les programmes d'aide disponibles, visitez la section dédiée sur le site internet de la Ville.

Between 2001/2002 and 2021/2022, the numer of deaths in Montréal, in the Canadian province of Québec, increased overall, for both sexes. There was a spike between 2019 and 2021, mainly due to the COVID-19 pandemic. In 2021/2022, more than ****** women and ****** men died in Montréal. More information on Québec can be found here.

BackgroundPost COVID-19 condition (PCC) is increasingly recognized as a debilitating condition characterized by persistent symptoms following SARS-CoV-2 infection. Neuropsychological deficits, including cognitive impairments and fatigue, are prevalent in individuals with PCC. The PoCoRe study aimed to evaluate the burden of neuropsychological deficits in PCC patients undergoing multidisciplinary indoor rehabilitation and to describe possible changes in this symptomatology.MethodsThe PoCoRe study, a prospective, non-randomized, controlled longitudinal study, recruited PCC patients from six German indoor rehabilitation centers. Eligible participants underwent comprehensive neuropsychological assessments at admission and discharge. Various measures were employed, including the fatigue scale for motor functioning and cognition (FSMC), the Test Battery for Attention (TAP) and the Montreal Cognitive Assessment (MoCA).ResultsOut of the 1,086 recruited participants, a total of N = 701 participants were included in the main data analysis. The prevalence of fatigue on admission was high (84.6%) and decreased significantly by discharge (77.4%), with a mild effect size. Reaction times on the alertness subtest were abnormal in 70% of patients on admission and 50% on discharge. Sustained attention was abnormal in 55% of patients on admission, decreasing to 43% on discharge. These differences were significant with mild effect sizes. Furthermore, of the 27% of participants with pathological MoCA scores at admission, 63% improved to normative levels during rehabilitation, indicating a significant treatment effect (p ≤ 0.001). However, the MoCA demonstrated limited sensitivity in detecting attention deficits.ConclusionThe PoCoRe study highlights the high prevalence of neuropsychological deficits and fatigue in PCC patients, with notable improvements observed following multidisciplinary rehabilitation. Challenges remain in accurately identifying and addressing these deficits, underscoring the importance of comprehensive neuropsychological assessment and tailored rehabilitation interventions. Further research is warranted to optimize screening tools and enhance neuropsychological care for PCC patients in both rehabilitation and outpatient settings.

To support Montreal businesses during this exceptional situation, the City of Montreal's Economic Development Department has implemented an initiative to proactively inform Montreal businesses of the assistance programs available. A short call allowed them to better understand their concerns in the particular context of Covid-19 and to share information that could help them adapt to the situation. This data set brings together some of the responses of businesses that spoke with the City of Montreal, making it possible to draw up a certain portrait of the reality experienced by Montreal businesses. For more details on the measures put forward by the City of Montreal and the assistance programs available, visit the dedicated section on the City's website: https://montreal.ca/articles/covid-19-mesures-en-soutien-aux-entreprises-montrealaises

To support Montreal businesses during this exceptional situation, the City of Montreal's Economic Development Department has implemented an initiative to proactively inform Montreal businesses of the assistance programs available. A short call allowed them to better understand their concerns in the particular context of Covid-19 and to share information that could help them adapt to the situation. This data set brings together some of the responses of businesses that spoke with the City of Montreal, making it possible to draw up a certain portrait of the reality experienced by Montreal businesses. For more details on the measures put forward by the City of Montreal and the assistance programs available, visit the dedicated section on the City's website: https://montreal.ca/articles/covid-19-mesures-en-soutien-aux-entreprises-montrealaises

The selected police-reported crime statistics during the COVID-19 pandemic special survey collects timely monthly aggregate information on the types of police-reported activity, including criminal incidents and other calls for service, which occurred during the months of the COVID-19 pandemic.

The state of downtown is a free and accessible quarterly report that gives the pulse of socio-economic activity in downtown Montreal. The Downtown State aims to monitor the evolution of the COVID-19 crisis and to inform recovery efforts.

Dans le contexte de la lutte contre la COVID-19, l'agglomération de Montréal a rapidement repensé l'espace public pour favoriser les déplacements actifs et sécuritaires. L’objectif : permettre aux gens de se déplacer de façon active en respectant les consignes de distanciation physique prescrites par la Direction de la santé publique. Cet ensemble de données localise les corridors sanitaires IMPLANTÉS ainsi que les voies actives et sécuritaires PLANIFIÉES tels que rapportés par les arrondissements et villes liées de l’Agglomération. Les voies actives et sécuritaires sont présentées telles qu'annoncées lors de l'annonce du 15 mai 2020.

Note: Ces données sont une image des corridors implantés et planifiés en date du 21 mai 2020, certains changements apportés sur le terrain ne sont pas reflétés dans cet ensemble. Pour toutes informations complémentaires par rapport à la crise COVID-19, merci de consulter la section dédiée sur le site internet de la Ville de Montréal.

The COVID-19 pandemic and the resulting Large-Scale Social Restrictions (PSBB) have significantly disrupted routine healthcare services, particularly in high TB burden countries. Despite initial expectations that the private health sector would lead in addressing TB, preliminary data suggests that the sector has shrunk or collapsed in many areas. Private facilities struggled to stay open during PSBB, and providers were reluctant to treat people with respiratory symptoms. Private healthcare costs have soared, especially for hospitalizations. Through this project, we were able to measure pre-treatment costs and factors associated with those costs from the perspective of patients during the COVID-19 pandemic in Bandung, Indonesia. It was found that the median total pre-treatment cost was $35.45 with the highest median cost experienced by participants from private hospitals. The rapid antigen and PCR for SARS-CoV-2 emerged as additional medical costs among 26% of participants recruited in private hospitals. Several factors are associated with higher pre-treatment costs including visiting more than 6 providers before diagnosis, presenting first at a private hospital and private practitioners, and being diagnosed in the private health sector. During the COVID-19 pandemic, people with TB faced significant out-of-pocket costs for diagnosis and treatment, highlighting the importance of early detection and identification in reducing pre-diagnostic TB costs.

The fight against COVID-19 has transformed travel in urban areas. The City of Montreal therefore offers the Safe Active Ways (VAS) circuit. This new way of adopting travel is established in order to offer Montrealers the opportunity to travel in safe temporary accommodations in 2020-21. This data set corresponds to the cultural programming of the City of Montreal, whose main objective is to make culture accessible to citizens within VAS and throughout the metropolitan area. With this program, the City of Montreal aims to highlight the work of Montreal artists and creators and to promote cultural offerings outside the walls. An interactive map will be available on the City of Montreal's website, to identify the multitude of cultural activities in progress. This card will be updated and improved continuously over the weeks. Note: Data is evolving and projects will be added in the future.**This third party metadata element was translated using an automated translation tool (Amazon Translate).**

In 2023, the net absorption of office space in Montreal remained negative, meaning that more tenants moved out of office space than the ones that moved in during this period. The drastic decline was a result of the coronavirus (COVID-19) crisis. According to the forecast, office space absorption is expected to rise in 2024, reaching ***** million square feet. The uptick can also be seen on a national level.

Background: In Quebec, most COVID-19 deaths are from residents of long-term care facilities. Within a facility, some residents experience adverse symptoms and even death, while others show no symptoms or exhibit mild symptoms. The reasoning behind these differences remains unclear. Aims of the CITF-funded study: DISCoVER biobank aimed to optimize risk stratification for residents infected by COVID-19 in long-term care facilities by using interferon-based immunological markers. They also aimed to identify psychosocial and cardiovascular risk factors contributing to severe outcomes of COVID-19 and evaluate the impact of vaccination on disease severity. Methods: This cohort study recruited residents over the age of 65 from long-term care facilities in Montreal, Quebec, who were tested for COVID-19. On “day 0”, when participants’ COVID-19 test results were determined, they completed a psychosocial interview, questionnaires, optional qualitative psychosocial evaluations through in-depth interviews, and provided blood samples for plasma and a COVID test [1]. This process was repeated at follow ups 1-, 3-, and 6-months post “day 0”. Participants also provided a blood sample for plasma 7 days after day 0. Summary of the contributed data: Dataset includes baseline medical health record data from 115 participants. 80% of participants gave one or more blood samples for SARS-CoV-2 serology between August 2021 and July 2023. A total of 149 serological samples were collected. Variables include data in the following areas of information: demographics (age, sex, ethnicity), general health (smokes, chronic conditions, height and weight), longitudinal follow-up for COVID infection (test date and result), SARS-CoV-2 vaccination (dates of vaccine doses, side effects) and serology (antibodies against SARS-CoV-2 RBD, nucleocapsid, and spike proteins). [1]: Please contact original study team for psychosocial data.

Air Quality Forecast: Contaminant Concentration: Ozone: Canada: Montreal data was reported at 62.217 mcg/Cub m in 22 May 2025. This records an increase from the previous number of 35.491 mcg/Cub m for 21 May 2025. Air Quality Forecast: Contaminant Concentration: Ozone: Canada: Montreal data is updated daily, averaging 56.548 mcg/Cub m from Oct 2019 (Median) to 22 May 2025, with 2038 observations. The data reached an all-time high of 111.042 mcg/Cub m in 07 Jun 2021 and a record low of 6.773 mcg/Cub m in 26 Nov 2021. Air Quality Forecast: Contaminant Concentration: Ozone: Canada: Montreal data remains active status in CEIC and is reported by CEIC Data. The data is categorized under Global Database’s Canada – Table CAMS.AQF: Air Quality Forecast: Contaminant Concentration: Ozone: by Cities. [COVID-19-IMPACT]

Air Quality Forecast: Contaminant Concentration: PM10: Canada: Montreal data was reported at 3.095 mcg/Cub m in 22 May 2025. This records a decrease from the previous number of 8.061 mcg/Cub m for 21 May 2025. Air Quality Forecast: Contaminant Concentration: PM10: Canada: Montreal data is updated daily, averaging 12.586 mcg/Cub m from Oct 2019 (Median) to 22 May 2025, with 2038 observations. The data reached an all-time high of 147.568 mcg/Cub m in 06 Jun 2023 and a record low of 0.870 mcg/Cub m in 19 May 2025. Air Quality Forecast: Contaminant Concentration: PM10: Canada: Montreal data remains active status in CEIC and is reported by CEIC Data. The data is categorized under Global Database’s Canada – Table CAMS.AQF: Air Quality Forecast: Contaminant Concentration: PM10: by Cities. [COVID-19-IMPACT]

One of the most prevalent symptoms of post-COVID condition is cognitive impairment, which results in a significant degree of disability and low quality of life. In studies with large sample sizes, attention, memory, and executive function were reported as long-term cognitive symptoms. This study aims to describe cognitive dysfunction in large post-COVID condition individuals, compare objective neuropsychological performance in those post-COVID condition individuals with and without cognitive complaints, and identify short cognitive exams that can differentiate individuals with post-COVID symptoms from controls. To address these aims, the Nautilus project was started in June 2021. During the first year, we collected 428 participants’ data, including 319 post-COVID and 109 healthy controls (18–65 years old) from those who underwent a comprehensive neuropsychological battery for cognitive assessment. Scores on tests assessing global cognition, learning and long-term memory, processing speed, language and executive functions were significantly worse in the post-COVID condition group than in healthy controls. Montreal Cognitive Assessment, digit symbol test, and phonetic verbal fluency were significant in the binomial logistic regression model and could effectively distinguish patients from controls with good overall sensitivity and accuracy. Neuropsychological test results did not differ between those with and without cognitive complaints. Our research suggests that patients with post-COVID conditions experience significant cognitive impairment and that routine tests like the Montreal Cognitive Assessment, digit symbol, and phonetic verbal fluency test might identify cognitive impairment. Thus, the administration of these tests would be helpful for all patients with post-COVID-19 symptoms, regardless of whether cognitive complaints are present or absent.Study registrationwww.ClinicalTrials.gov, identifiers NCT05307549 and NCT05307575.